Related Experiment Videos
Naloxone and naltrexone. Application in COPD
1Ingalls Memorial Hospital, Harvey, Illinois.
Chest
|January 1, 1988
Summary
Naloxone and naltrexone, narcotic antagonists, improved breathing in COPD patients when other treatments failed. Abruptly stopping these drugs led to respiratory failure, suggesting their potential as an additional COPD therapy.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) presents significant respiratory challenges.
- Traditional medical therapies for COPD may not be effective in all patients.
Observation:
- Two patients with severe COPD, unresponsive to conventional treatments, were administered narcotic antagonists (naloxone and naltrexone) as a potential respiratory stimulant.
- Both patients exhibited notable improvements in respiratory function during the administration of these agents.
Findings:
- Discontinuation of naloxone and naltrexone resulted in the recurrence of respiratory failure in both patients.
- This suggests a direct role of narcotic antagonists in supporting respiratory function in these specific COPD cases.
Implications:
- Narcotic antagonists may represent a novel therapeutic option for select COPD patients.
- Further research is warranted to explore the efficacy and safety of narcotic antagonists in managing COPD exacerbations.